Literature DB >> 6205165

Epitopes on foot-and-mouth disease virus outer capsid protein VP1 involved in neutralization and cell attachment.

B Baxt, D O Morgan, B H Robertson, C A Timpone.   

Abstract

Foot-and-mouth disease virus structural protein VP1 elicits neutralizing and protective antibody and is probably the viral attachment protein which interacts with cellular receptor sites on cultured cells. To study the relationships between epitopes on the molecule related to neutralization and cell attachment, we tested monoclonal antibodies prepared against type A12 virus, isolated A12 VP1, and a CNBr-generated A12 VP1 fragment for neutralization and effect on viral absorption. The antibodies selected for analysis neutralized viral infectivity with varying efficiencies. One group of antibodies caused a high degree of viral aggregation and inhibited the adsorption of virus to cells by 50 to 70%. A second group of antibodies caused little or no viral aggregation but inhibited the adsorption of virus to cells by 80 to 90%. One antibody, which is specific for the intact virion, caused little viral aggregation and had no effect on the binding of virus to specific cellular receptor sites. Thus, at least three antigenic areas on the surface of foot-and-mouth disease virus which were involved in neutralization were demonstrated. One of the antigenic sites appears to have been responsible for interaction with the cellular receptor sites on the surface of susceptible cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6205165      PMCID: PMC254438     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  CHEMICAL PHYSICAL PROPERTIES OF VIRTUALLY PURE FOOT-AND-MOUTH DISEASE VIRUS.

Authors:  H L BACHRACH; R TRAUTMAN; S S BREESE
Journal:  Am J Vet Res       Date:  1964-03       Impact factor: 1.156

2.  Neutralization of poliovirus: a hypothesis to explain the mechanism and the one-hit character of the neutralization reaction.

Authors:  B Mandel
Journal:  Virology       Date:  1976-02       Impact factor: 3.616

3.  Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production.

Authors:  H G Bahnemann
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

4.  Immunochemical studies of foot-and-mouth disease. VII. Characterization of foot-and-mouth disease virus concentrated by polyethylene glycol precipitation.

Authors:  G G Wagner; J L Card; K M Cowan
Journal:  Arch Gesamte Virusforsch       Date:  1970

5.  The interaction of neutralized poliovirus with HeLa cells. I. Adsorption.

Authors:  B Mandel
Journal:  Virology       Date:  1967-02       Impact factor: 3.616

6.  Comparison of the major antigenic determinants of different serotypes of foot-and-mouth disease virus.

Authors:  A Cheung; J DeLamarter; S Weiss; H Küpper
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

7.  Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus.

Authors:  H L Bachrach; D M Moore; P D McKercher; J Polatnick
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

8.  Use of sarcoma 180/TG to prepare hyperimmune ascitic fluid in the mouse.

Authors:  A C Sartorelli; D S Fischer; W G Downs
Journal:  J Immunol       Date:  1966-04       Impact factor: 5.422

9.  Natural variation of poliovirus neutralization epitopes.

Authors:  R Crainic; P Couillin; B Blondel; N Cabau; A Boué; F Horodniceanu
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

10.  Immunochemical studies of foot-and-mouth disease. V. Antigenic variants of virus demonstrated by immunodiffusion analyses with 19S but not 7S antibodies.

Authors:  K M Cowan
Journal:  J Exp Med       Date:  1969-02-01       Impact factor: 14.307

View more
  46 in total

Review 1.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

2.  Capsid intermediates assembled in a foot-and-mouth disease virus genome RNA-programmed cell-free translation system and in infected cells.

Authors:  M J Grubman; D O Morgan; J Kendall; B Baxt
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

3.  Different virus-precipitating activities of neutralizing monoclonal antibodies that recognize distinct sites of poliovirus particles.

Authors:  K Taniguchi; S Urasawa
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

4.  Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor.

Authors:  S Neff; D Sá-Carvalho; E Rieder; P W Mason; S D Blystone; E J Brown; B Baxt
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Relationship between poliovirus neutralization and aggregation.

Authors:  A A Thomas; R Vrijsen; A Boeyé
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

6.  Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis viruses.

Authors:  S Nitayaphan; M M Toth; R P Roos
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

7.  Foot-and-mouth disease virus-neutralizing antibodies induced in mice by anti-idiotypic antibodies.

Authors:  A E Garmendia; D O Morgan; B Baxt
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

8.  Monoclonal and polyclonal antibodies specific for foot and mouth disease virus type A and type O VP1.

Authors:  Jin Gu Cho; Yeong Joon Jo; Jong-Hyuk Sung; Jang-Kwan Hong; Ji-Hyeon Hwang; Jong-Hyeon Park; Kwang-Nyeong Lee; Sang Gyu Park
Journal:  Hybridoma (Larchmt)       Date:  2012-10

9.  Interactions of foot-and-mouth disease virus with soluble bovine alphaVbeta3 and alphaVbeta6 integrins.

Authors:  Hernando Duque; Michael LaRocco; William T Golde; Barry Baxt
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  A conserved domain in the leader proteinase of foot-and-mouth disease virus is required for proper subcellular localization and function.

Authors:  Teresa de los Santos; Fayna Diaz-San Segundo; James Zhu; Marla Koster; Camila C A Dias; Marvin J Grubman
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.